About Joseph Pierre
Form D filings for 32 Biosciences in 2024 list Joseph Pierre as director.
Joseph Pierre first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Joseph Pierre in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Joseph Pierre works with at each company, as listed on that company's latest Form D.
32 Biosciences, Inc. · Form D, May 31, 2024
BY
Brian Yoor
Director
EC
Eugene Chang
Director
JC
Jaime Contreras
Director
JA
John Alverdy
Director
PF
Peter Farmakis
Chief Executive Officer and director